Detection of vascular endothelial function post-COVID-19 with carotid artery reactivity testing.

Detection of vascular endothelial function post-COVID-19 with carotid artery reactivity testing. - COVAS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON49993

Enrollment

200

Registered

2020-07-02

Start date

2020-07-23

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endothelial dysfunction vascular damage

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Confirmed severe acute respiratory syndrome corona virus 2 (SARS-CoV2) infection by polymerase chain reaction on nasopharyngeal swab, sputum or bronchoalveolar lavage. - 6 to 20 weeks after resolution of COVID-19 related symptoms - >= 16 years old

Exclusion criteria

Exclusion criteria: - Recent (

Design outcomes

Primary

Measure	Time frame
Endothelial dysfunction as determined by carotid artery reactivity (CAR) test	—

Secondary

Measure	Time frame
Major adverse cardiovascular events (MACE) within one year post-COVID-19 is an exploratory endpoint. In this study, MACE include non-fatal myocardial infarction, non-fatal ischemic stroke, acute limb ischemia, need for revascularization, amputation and cardiovascular death.	—

Countries

Netherlands

Outcome results